The U.S. FDA Approves First Cream for Chronic Hand Eczema: What Will This Nod Mean for Patients? July 25, 2025
U.S. FDA Grants Breakthrough Device Designation to Castle Biosciences’ DecisionDx-Melanoma Test July 24, 2025
Inside the SLE Pipeline: Patient Enrollment Complete in Phase 2b Trial of Alumis Inc.’s Oral TYK2 Inhibitor July 24, 2025